Literature DB >> 26690643

Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs.

William K Lee1, M J S Milloy1, John Walsh2, Paul Nguyen1, Evan Wood1, Thomas Kerr1.   

Abstract

OBJECTIVE: Suboptimal adherence to antiretroviral therapy (ART) among HIV-infected people who use illicit drugs (PWUD) remains a significant concern, and there is a lack of effective adherence interventions for this population. Therefore, we sought to identify psychosocial determinants of optimal adherence, including adherence self-efficacy and outcome expectancies, with the aim of informing interventions designed to improve adherence among PWUD.
METHOD: From December 2005 to November 2013, we collected data from the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS), a prospective cohort of PWUD in Vancouver, Canada. We used multivariable generalized estimating equations (GEE) analysis to identify longitudinal factors independently associated with 95% or greater adherence to ART.
RESULTS: Among 667 participants, including 220 (33%) women, 391 (59%) had 95% or greater ART adherence at baseline. In multivariable GEE analysis, adherence self-efficacy, adjusted odds ratio (AOR) = 1.16, 95% confidence interval (CI) [1.11, 1.21] per 10-point increase, was independently and positively associated with adherence, while negative outcome expectancy, AOR = 0.95, 95% CI [0.93, 0.98], was negatively associated.
CONCLUSION: In light of the ongoing challenges associated with ART adherence among HIV-positive PWUD, and our findings of associations between adherence, self-efficacy, and outcomes expectancies, tailored intervention strategies based on constructs of social learning theory should be implemented and evaluated to improve adherence among HIV-infected PWUD. (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26690643      PMCID: PMC4760876          DOI: 10.1037/hea0000310

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  48 in total

1.  Functional health literacy, medication-taking self-efficacy and adherence to antiretroviral therapy.

Authors:  Alison M Colbert; Susan M Sereika; Judith A Erlen
Journal:  J Adv Nurs       Date:  2012-04-11       Impact factor: 3.187

2.  Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.

Authors:  Jane M Simoni; David Huh; Ira B Wilson; Jie Shen; Kathy Goggin; Nancy R Reynolds; Robert H Remien; Marc I Rosen; David R Bangsberg; Honghu Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

3.  Impulsivity, cognitive function, and their relationship in heroin-dependent individuals.

Authors:  H Zeng; Tatia M C Lee; J H Waters; Kwok-Fai So; Pak C Sham; R S Schottenfeld; C Marienfeld; Marek C Chawarski
Journal:  J Clin Exp Neuropsychol       Date:  2013-09-17       Impact factor: 2.475

4.  Predictors of medication adherence among HIV-positive women in North America.

Authors:  Lynda A Tyer-Viola; Inge B Corless; Alison Webel; Paula Reid; Kathleen M Sullivan; Patrice Nichols
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2014-02-06

5.  Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users.

Authors:  B Mann; M-J Milloy; T Kerr; R Zhang; J Montaner; E Wood
Journal:  HIV Med       Date:  2012-05-02       Impact factor: 3.180

6.  Social cognitive theory: an agentic perspective.

Authors:  A Bandura
Journal:  Annu Rev Psychol       Date:  2001       Impact factor: 24.137

7.  Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.

Authors:  K V Heath; R S Hogg; K J Chan; M Harris; V Montessori; M V O'Shaughnessy; J S Montanera
Journal:  AIDS       Date:  2001-01-26       Impact factor: 4.177

Review 8.  Treatment of antiretroviral-drug-resistant HIV-1 infection.

Authors:  Steven G Deeks
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

9.  Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.

Authors:  Adam Gonzalez; Matthew J Mimiaga; Jared Israel; C Andres Bedoya; Steven A Safren
Journal:  AIDS Behav       Date:  2013-01

Review 10.  HIV-1 antiretroviral resistance: scientific principles and clinical applications.

Authors:  Michele W Tang; Robert W Shafer
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546

View more
  7 in total

1.  Addressing the Medical and Support Service Needs of People Living with HIV (PLWH) through Program Collaboration and Service Integration (PCSI).

Authors:  Stephanie Bernard; Amrita Tailor; Patricia Jones; Donna E Alexander
Journal:  Calif J Health Promot       Date:  2016

2.  Predictors of Antiretroviral Adherence Self-efficacy Among People Living With HIV/AIDS in a Canadian Setting.

Authors:  William K Lee; Michael John S Milloy; Ekaterina Nosova; John Walsh; Thomas Kerr
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

3.  The importance of domain-specific self-efficacy assessment for substance use and HIV care continuum outcomes among adults in an urban HIV clinic network.

Authors:  Tyrel J Starks; Simone J Skeen; S Scott Jones; Brett M Millar; Sitaji Gurung; Christopher Ferraris; Ana Ventuneac; Jeffrey T Parsons; Martha A Sparks
Journal:  AIDS Care       Date:  2021-03-22

4.  Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.

Authors:  Jan Klimas; Huiru Dong; Nadia Fairbairn; Eugenia Socías; Rolando Barrios; Evan Wood; Thomas Kerr; Julio Montaner; M-J Milloy
Journal:  Addict Sci Clin Pract       Date:  2018-02-07

Review 5.  A perspective on nonadherence to drug therapy: psychological barriers and strategies to overcome nonadherence.

Authors:  Leslie R Martin; Cheyenne Feig; Chloe R Maksoudian; Kenrick Wysong; Kate Faasse
Journal:  Patient Prefer Adherence       Date:  2018-08-22       Impact factor: 2.711

6.  Factors associated with readiness to start antiretroviral therapy (ART) among young people (15-24 years) at four HIV clinics in Mulago Hospital, Uganda.

Authors:  Jonathan Nkalubo; Moureen Mugaba; Ignatius Asasira; Racheal Nakiganda; Florence Namutebi; Nick Ntore Arnaud; Nicholas Kagumba Musisi; Trinity Abasira; Pius Jemba; Racheal Ndyabawe; Rosette Tumuhairwe; Charles Batte; Sabrina Bakeera-Kitaka
Journal:  Afr Health Sci       Date:  2021-12       Impact factor: 0.927

7.  Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.

Authors:  Oluwadamilola Jolayemi; Laura M Bogart; Erik D Storholm; David Goodman-Meza; Elena Rosenberg-Carlson; Rebecca Cohen; Uyen Kao; Steve Shoptaw; Raphael J Landovitz
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.